SUMO-1 CRISPR Knockout and Activation Products (h)
Descrição
SUMO-1 CRISPR Knockout and Activation Plasmids (h) designed to edit, knockdown or upregulate human SUMO-1 gene expression
Identification of DAXX as a restriction factor of SARS-CoV-2 through a CRISPR/Cas9 screen
Crosstalk between SUMOylation and ubiquitylation controls DNA end resection by maintaining MRE11 homeostasis on chromatin
human USE1-specific CRISPR/Cas9 KO Plasmid, HDR Plasmid, Double Nickase Plasmids, CRISPR Activation Plasmids and Lentiviral Activation Particles
USE1 CRISPR Plasmids (h)
A conserved SUMO pathway repairs topoisomerase DNA-protein cross-links by engaging ubiquitin-mediated proteasomal degradation
Frontiers Natural Products Against Renal Fibrosis via Modulation of SUMOylation
CRISPR–Cas9-mediated base-editing screening in mice identifies DND1 amino acids that are critical for primordial germ cell development
SUMO-1 CRISPR Knockout and Activation Products (h)
Cell Lines For Studying Sumoylation
Cancers, Free Full-Text
Frontiers Identification of UBE2I as a Novel Biomarker in ccRCC Based on a Large-Scale CRISPR-Cas9 Screening Database and Immunohistochemistry
IJMS, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)
